Skip to Main Content

Genome Research in African American Scleroderma Patients (GRASP Study)

Conditions

Diseases of the Integumentary System | Immune System

What is the purpose of this trial?

The goal of the GRASP Study (Genome Research in African American Scleroderma Patients is to better understand how African American patients are affected by scleroderma. The Yale Scleroderma Program has partnered with Johns Hopkins University and the National Human Genome Research Institute to collect clinical data and blood samples from African American patients diagnosed with scleroderma to achieve this goal.

  • Trial with
    Johns Hopkins University
  • Start Date
    03/17/2020
  • End Date
    12/31/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/15/2021
  • Study HIC
    #2000027458